Simplifying Global Compliance
FDA Panel Struggles to Agree on Effectiveness of Tumor Device
Devices & Diagnostics Letter
An FDA advisory panel reached deadlock over the effectiveness of a novel device that blasts glioblastoma multiforme (GBM) brain tumors with an electrical field, with the panel chair breaking the tie in favor of the device.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing